TWiV 1014: Clinical update with Dr. Daniel Griffin
This Week in Virology - En podkast av Vincent Racaniello
Kategorier:
In his weekly clinical update, Dr. Griffin discusses estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status, smart thermometer–based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic, COVID-19 vaccine mandates, changing severity and epidemiology of adults hospitalized with COVID-19 in the United States after introduction of COVID-19 vaccines, effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. veterans, national trends in anticoagulation therapy for COVID-19 hospitalized adults in the United States, development of a definition of postacute sequelae of SARS-CoV-2 infection, neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms, long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms, and coronary microvascular health in symptomatic patients with prior COVID-19 infection. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Estimates of SARS-CoV-2 seroprevalence and incidence of infections among blood donors, by vaccination status (CDC) Smart thermometer–based surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic (JAMA) COVID-19 vaccine mandates (GOV) Changing epidemiology of adults hospitalized with COVID-19 after introduction of vaccines (CID) Effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. Veterans (ACP Journals) National trends in Anticoagulation therapy for COVID-19 (IDSA) Development of a definition of postacute sequelae of SARS-CoV-2 infection (JAMA) Neuroinflammation after COVID-19 with depressive and cognitive symptoms (JAMA) Long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms (OFID) Coronary microvascular health in patients with prior COVID-19 infection (EACVI) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1014 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]